Your browser doesn't support javascript.
loading
Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey.
Kim, Ji Hyun; Lee, Yumi; Kim, Da-Young; Kim, Sinae; Seo, Sang-Soo; Kang, Sokbom; Park, Sang-Yoon; Lim, Myong Cheol.
Afiliação
  • Kim JH; Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea.
  • Lee Y; Department of Nursing, Pukyong National University, Busan, Korea.
  • Kim DY; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
  • Kim S; Biostatistics Collaboration Team, Research Core Center, National Cancer Center, Goyang, Korea.
  • Seo SS; Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea.
  • Kang S; Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea.
  • Park SY; Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea.
  • Lim MC; Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea.
J Gynecol Oncol ; 35(1): e3, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37681357
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article